For Quick Alerts
For Daily Alerts

Dr Reddy's Labs Shares Hit All-Time High After Q1 Results


On Thursday, shares of Dr Reddy's Laboratories rose nearly 6 percent to a new all-time high of Rs 4,544 after the company reported a higher than expected profit for the June-ended quarter.

Dr Reddy's Labs Shares Hit All-Time High After Q1 Results

The multinational pharma company posted a 12.6 percent fall in consolidated net profit at Rs 579 crore for the first quarter of 2020-21 from Rs 662.8 crore in the same period a year ago. However, its June 2019 profit was boosted by the settlement claim of Rs 345.7 crore received from Celgene in April 2019 with respect to the cancer drug.

Dr Reddy's Lab's revenue from operations during June ended quarter was up by 15 percent year-on-year to Rs 4,418 crore. Its gross margin was at 56 percent in the April-June period, up by 4.3 percent against 51.7 percent a year ago and 51.5 percent in the previous quarter.

Its EBITDA (earnings before interest, taxes, depreciation, and amortization) improved by 2 percent year-on-year to Rs 1,162 crore but margin dropped 320 basis points to 26.3 percent.

Read more about: dr reddys
Company Search
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more